NASDAQ:IBRX | Insider Transactions — Page 2 | ImmunityBio, Inc.

IBRX Insider Transactions — Page 2

123 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–123; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
GORLIN STEVEDirector2017-09-12Sale35,811.0$6.03
GORLIN STEVEDirector2017-09-11Sale53,307.0$6.03
GORLIN STEVEDirector2017-09-08Sale14,723.0$6.12
Thomas John CDirector2017-06-20Sale10,000.0$7.54
Thomas John CDirector2017-06-20Sale20,000.0$7.44
Thomas John CDirector2017-06-20Sale10,000.0$7.43
GORLIN STEVEDirector2017-06-20Sale20,000.0$8.13
GORLIN STEVEDirector2017-06-20Sale20,000.0$7.43
Thomas John CDirector2016-11-25Sale6,168.0$7.5
Thomas John CDirector2016-11-23Sale7,719.0$7.5
Thomas John CDirector2016-11-23Sale7,000.0$7.5
Thomas John CDirector2016-11-22Sale13,000.0$7.5
Simon Barry J.President and COO2016-09-08Sale30,000.0$7.4
Simon Barry J.President and COO2016-09-07Sale2,000.0$8.84
SOON-SHIONG PATRICKChairman and CEO2016-07-07Purchase5,618,326.0
Chan Soon-Shiong Family FoundationTenPercentOwner2016-07-07Purchase5,618,326.0
Wilson AngelaChief Financial Officer2015-12-10Purchase3,022.0$15.33
Wilson AngelaChief Financial Officer2015-12-10Purchase76.0$15.31
Wilson AngelaChief Financial Officer2015-12-10Purchase167.0$15.28
SOON-SHIONG PATRICKChairman and CEO2015-08-21Purchase450,000.0$23.0
MP 13 Ventures, LLCTenPercentOwner2015-08-21Purchase450,000.0$23.0
Cambridge Equities, LPTenPercentOwner2015-08-21Purchase450,000.0$23.0
GORLIN STEVEDirector2015-08-21Sale450,000.0$23.0